跳至主要内容
临床试验/TCTR20210831003
TCTR20210831003尚未招募4 期

The Efficacy of Ursodeoxycholic acid (UDCA) on Liver Regeneration After Major Hepatectomy

Research Fund of Faculty of Medicine, Chiang Mai University0 个研究点目标入组 60 人开始时间: 2021年8月31日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • 1. Age over 18 years
  • 2. Elective major hepatectomy due to liver tumors
  • 3. ICG R-15 less than 10%
  • Obstructive jaundice case: TB < 3 mg/dL
  • 4.Written informed consent

排除标准

  • 1. Presence of medical conditions putting the individual patient at increased risk for not tolerating hepatic resection
  • - Liver cirrhosis Child-Pugh B or C
  • - ICG-R 15 more than 10%
  • - Platelet less than 150,000 cells/cu.mm
  • - Coagulopathy: INR > 1.5
  • 2. Hypersensitivity to Ursodeoxycholic acid (UDCA)
  • 3. Hypersensitivity to contrast media
  • 4. Participation in other clinical trials or observation period of competing trials interfering with the endpoints of this trial
  • 5. Suspected lack of compliance
  • 6. Impaired mental status or language problems
  • 7. Refusal to take part in the study

研究者

发起方
Research Fund of Faculty of Medicine, Chiang Mai University

相似试验